Compounds > benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide
Page last updated: 2024-08-21

benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and edrophonium chloride

benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide has been researched along with edrophonium chloride in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Dohnal, V; Dolezal, M; Holas, O; Hrabinova, M; Komloova, M; Kuca, K; Musilek, K; Nachon, F; Pohanka, M1
Dohnal, V; Gunn-Moore, F; Holas, O; Horova, A; Komloova, M; Kuca, K; Musilek, K1
Dolezal, M; Horova, A; Hrabinova, M; Jun, D; Komloova, M; Kuca, K; Musilek, K; Vinsova, J1

Other Studies

4 other study(ies) available for benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and edrophonium chloride

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Humans; Isoquinolines; Models, Molecular; Molecular Structure; Myasthenia Gravis; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship

2011
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Bioorganic & medicinal chemistry letters, 2011, Apr-15, Volume: 21, Issue:8

    Topics: Acetylcholinesterase; Ambenonium Chloride; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Edrophonium; Humans; Kinetics; Molecular Dynamics Simulation; Myasthenia Gravis; Protein Binding; Quinolinium Compounds; Recombinant Proteins; Structure-Activity Relationship

2011
Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Dec-15, Volume: 23, Issue:24

    Topics: Acetylcholinesterase; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Enzyme Activation; Humans; Models, Molecular; Protein Binding; Protein Structure, Tertiary; Pyridinium Compounds; Quinolinium Compounds; Recombinant Proteins; Structure-Activity Relationship

2013